Home > Newsletters > International Pharmaceutical Regulatory Monitor > Drug Withdrawals in EU Must Be Justified Under New Pharmacovigilance Rules
International Pharmaceutical Regulatory Monitor
October 2012 | Vol. 40 No. 10
Drug Withdrawals in EU Must Be Justified Under New Pharmacovigilance Rules
Manufacturers withdrawing their drugs from any market in the EU will now have to notify competent authorities of the reason, according to amended pharmacovigilance rules adopted by the Council of the European Union Oct. 4.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.